MEDICINES CONTROL COUNCIL

Size: px
Start display at page:

Download "MEDICINES CONTROL COUNCIL"

Transcription

1 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN CEFAZOLIN 1 g CEFAZOLIN SODIUM CEFAZOLIN 1,0 g 41/7.1.3/0504 PHARMACARE LIMITED VERSYLON 2 mg PERINDOPRIL TERT- BUTYLAMINE 2,0 mg 41/7.1.3/0505 PHARMACARE LIMITED VERSYLON 4 mg PERINDOPRIL TERT- BUTYLAMINE 4,0 mg 41/7.1.3/0506 PHARMACARE LIMITED VERSYLON 8 mg PERINDOPRIL TERT- BUTYLAMINE 8,0 mg 41/21.2/0658 ACCORD HEALTHCARE 41/11.4.3/0663 ACCORD HEALTHCARE 41/25/0756 B BRAUN MEDICAL (PTY) ACCORD GLIMEPIRIDE 4 ACCORD OMEPRAZOLE 40 mg INJECTION NUTRIFLEX LIPID PLUS GLIMEPIRIDE 4,0 mg OMEPRAZOLE 40,0 mg L-isoleucine 2,26 g L-leucine 3,01 g L-methionine 1,88 g L-lysine 2,18 g L-phenylalanine 3,37 g L-threonine 1,74 g L-tryptophan 0,54 g L-valine 2,50 g L-arginine 2,59 g L-histidine 1,20 g L-alanine 4,66 g Glycine 1,58 g L-proline 3,26 g Notification of Feb11v1.doc Apr 2011 Page 1 of 8

2 41/25/0757 B BRAUN MEDICAL (PTY) 41/25/0758 B BRAUN MEDICAL (PTY) NUTRIFLEX LIPID PERI NUTRIFLEX LIPID PLUS WITHOUT ELECTROLYTES L-serine 2,88 g Sodium chloride 0,402 g Calcium chloride 0,47 g Magnesium acetate 0,686 g Potassium acetate 2,747 g Sodium dihydrogen phosphate 1,872 g Glucose 1 Aspartic acid 1,44 g Glutamic acid 3,37 g Sodium hydroxide 0,781 g Sodium acetate 0,222 g Zinc acetate 5,264 g Soya oil L-isoleucine 1,87 g L-leucine 2,50 g L-methionine 1,57 g L-lysine 1,81 g L-phenylalanine 2,81 g L-threonine 1,46 g L-tryptophan 0,46 g L-valine 2,08 g L-arginine 2,16 g L-histidine 1,00 g L-alanine 3,88 g Glycine 1,32 g L-proline 2,72 g L-serine 2,40 g Sodium chloride 0,865 g Calcium chloride 0,353 g Magnesium acetate 0,515 g Potassium acetate 2,354 g Sodium dihydrogen phosphate 0,936 g Glucose 64,0 g Aspartic acid 1,20 g Glutamic acid 2,80 g Sodium hydroxide 0,64 g Sodium acetate 0,435 g Zinc acetate 5,30 g Soya oil L-isoleucine 2,26 g L-leucine 3,01 g L-methionine 1,88 g L-lysine 2,18 g L-phenylalanine 3,37 g L-threonine 1,74 g L-tryptophan 0,54 g Notification of Feb11v1.doc Apr 2011 Page 2 of 8

3 41/25/0759 B BRAUN MEDICAL (PTY) 42/7.1.3/0325 ACCORD HEALTHCARE 42/7.1.3/0326 ACCORD HEALTHCARE NUTRIFLEX LIPID SPECIAL LOSAAR PLUS 50/12,5 LOSAAR PLUS 100/25 L-valine 2,50 g L-arginine 2,59 g L-histidine 1,20 g L-alanine 4,66 g Glycine 1,58 g L-proline 3,26 g L-serine 2,88 g Glucose 1 Aspartic acid 1,44 g Glutamic acid 3,37 g Soya oil L-isoleucine 3,28 g L-leucine 4,38 g L-methionine 2,74 g L-lysine 3,18 g L-phenylalanine 4,92 g L-threonine 2,54 g L-tryptophan 0,80 g L-valine 3,60 g L-arginine 3,78 g L-histidine 1,75 g L-alanine 6,79 g Glycine 2,31 g L-proline 4,76 g L-serine 4,20 g Sodium chloride 0,378 g Calcium chloride 0,623 g Magnesium acetate 0,91 g Potassium acetate 3,689 g Sodium dihydrogen phosphate 2,496 g Glucose 144,0 g Aspartic acid 2,10 g Glutamic acid 4,91 g Sodium hydroxide 1,171 g Sodium acetate 0,25 g Zinc acetate 7,02 g Soya oil 12,5 mg Notification of Feb11v1.doc Apr 2011 Page 3 of 8

4 42/5.7.1/0339 SANOFI-AVENTIS 43/20.2.8/0581 ARROW PHARMA 44/20.2.8/0106 ADCOCK INGRAM LIMITED 44/20.2.8/0107 ADCOCK INGRAM LIMITED A40/3/0326 A40/3/0327 ECO ECO 41/26/0162 CIPLA LIFE SCIENCES 41/26/0163 CIPLA LIFE SCIENCES 41/1.2/0297 BOUWER BARTLETT 41/26/0423 CIPLA MEDPRO (PTY) 41/26/0424 CIPLA MEDPRO (PTY) 41/26/0425 CIPLA MEDPRO (PTY) 41/25/0760 B BRAUN MEDICAL (PTY) TELFAST SUSPENSION ARROW EFAVIRENZ ADCO LAMIVUDINE AND ZIDOVUDINE 150/300 ZILAM TABLETS MICROVISC MICROVISC PLUS CIPLA DOCETAXEL 20 CIPLA DOCETAXEL 80 GLENMARK CITALOPRAM 20 mg CIPLA PACLITAXEL 30 mg/5 ml CIPLA PACLITAXEL 100 mg/16,7 ml CIPLA PACLITAXEL 300 mg/50 ml NUTRIFLEX LIPID SPEICAL WITHOUT ELECTROLYTES Each 5,0 ml suspension FEXOFENADINE HYDROCHLORIDE 30,0 mg EFAVIRENZ 600,0 mg LAMIVUDINE 1 ZIDOVUDINE 300,0 mg LAMIVUDINE 1 ZIDOVUDINE 300,0 mg Each 1,0 ml solution SODIUM HYALURONATE 10,0 mg Each 1,0 ml solution SODIUM HYALURONATE 14,0 mg DOCETAXEL 20,0 mg DOCETAXEL 80,0 mg CITALOPRAM HYDROBROMIDE CITALOPRAM 20,0 mg Each 5,0 ml vial PACLITAXEL 30,0 mg Each 20,0 ml vial PACLITAXEL Each 50,0 ml vial PACLITAXEL 300,0 mg L-isoleucine 3,28 g L-leucine 4,38 g L-methionine 2,74 g L-lysine 3,18 g L-phenylalanine 4,92 g L-threonine 2,54 g L-tryptophan 0,80 g L-valine 3,60 g L-arginine 3,78 g L-histidine 1,75 g L-alanine 6,79 g Glycine 2,31 g L-proline 4,76 g L-serine 4,20 g Glucose 144,0 g Aspartic acid 2,10 g Glutamic acid 4,91 g Notification of Feb11v1.doc Apr 2011 Page 4 of 8

5 41/3.1/0762 PFIZER LABORATORIES 41/3.1/0763 PFIZER LABORATORIES 41/11.5/0764 ARROW PHARMA 41/7.1/0782 MERCK GENERICS RSA 41/7.1/0783 MERCK GENERICS RSA ENBREL 25 mg PS ENBREL 50 mg PS ANLAC SYRUP MERCK AMLODIPINE 5 MERCK AMLODIPINE 10 41/5.2/0990 PHARMACARE LIMITED ASPEN GALANTAMINE 12 mg 41/5.2/0991 PHARMACARE LIMITED ASPEN GALANTAMINE 8 mg Soya oil Each pre-filled syringe ETANERCEPT Each pre-filled syringe ETANERCEPT Each 5,0 ml syrup LACTULOSE 5,0 mg AMLODIPINE BESYLATE AMLODIPINE 5,0 mg AMLODIPINE BESYLATE AMLODIPINE 10,0 mg GALANTAMINE 12,0 mg GALANTAMINE 8,0 mg 41/7.1.3/1000 SPECPHARM NETRASOL CO 50 12,5 mg 41/7.1.3/1001 SPECPHARM NETRASOL CO /5.3/1015 SANDOZ S.A. GALANTIC 4 GALANTAMINE HYDROBROMIDE GALANTAMINE 4,0 mg 41/5.3/1016 SANDOZ S.A. GALANTIC 8 GALANTAMINE HYDROBROMIDE GALANTAMINE 8,0 mg 41/5.3/1017 SANDOZ S.A. GALANTIC 12 GALANTAMINE HYDROBROMIDE GALANTAMINE 12,0 mg 41/7.1.3/1031 RANBAXY (S.A.) (PTY) RAN LOSARTAN PLUS 12,5mg Notification of Feb11v1.doc Apr 2011 Page 5 of 8

6 41/7.1.3/1034 RANBAXY (S.A.) (PTY) 41/7.1.3/1035 RANBAXY (S.A.) (PTY) 41/7.1.3/1036 RANBAXY (S.A.) (PTY) RAN LOSARTAN FORTE PLUS LOHYPE PLUS 50/12,5 LOHYPE FORTE PLUS 100/25 42/26/0020 PHARMACARE LIMITED ASPEN VINORELBIN 10 mg/1 ml 42/26/0021 PHARMACARE LIMITED ASPEN VINORELBIN 50 mg/5 ml 42/20.1.1/0079 XIXIA 42/20.1.1/0080 XIXIA 42/20.1.1/0081 XIXIA 42/5.7.1/0344 WINTHROP 42/3.2/0452 SANOFI AVENTIS SA MYLAN CEFTAZIDIME 500 mg MYLAN CEFTAZIDIME 1 g MYLAN CEFTAZIDIME 2 g FEXOFENADINE- WINTHROP SUSPENSION 6 mg/ml ACTONEL 75 mg 12,5 mg Each 1,0 ml vial VINORELBINE TARTRATE VINORELBINE 10,0 mg Each 5,0 ml vial VINORELBINE TARTRATE VINORELBINE CEFTAZIDIME PENTAHYDRATE CEFTAZIDIME 500,0 mg CEFTAZIDIME PENTAHYDRATE CEFTAZIDIME 1,0 g CEFTAZIDIME PENTAHYDRATE CEFTAZIDIME 2,0 g Each 5,0 ml suspension FEXOFENADINE HYDROCHLORIDE 30,0 mg RISEDRONATE SODIUM 75,0 mg 42/34/0664 PHARMAPLAN ZOBONE ZOLEDRONIC ACID 4,0 mg 42/20.2.8/0687 MSD ISENTRESS RALTEGRAVIR POTASSIUM RALTEGRAVIR 400,0 mg Notification of Feb11v1.doc Apr 2011 Page 6 of 8

7 42/20.2.8/0838 PHARMACARE LIMITED ASPEN ATAZANAVIR 150 mg 42/20.2.8/0839 PHARMACARE LIMITED ASPEN ATAZANAVIR 200 mg Each capsule ATAZANAVIR 1 Each capsule ATAZANAVIR 200,0 mg 42/1.2/1001 PHARMAPLAN NEXITO 10 ESCITALOPRAM OXALATE ESCITALOPRAM 10,0 mg 42/11.4.3/1003 ASTRAZENECA 43/20.2.8/0230 BLISS cc 43/20.2.8/0234 DEZZO TRADING 392 t/a INDO PHARMA 43/20.2.8/0235 DEZZO TRADING 392 t/a INDO PHARMA 43/20.2.8/0236 DEZZO TRADING 392 t/a INDO PHARMA 43/2.2/0247 AUROBINDO PHARMA 43/2.2/0257 AUROBINDO PHARMA 43/7.1.3/0493 AUROBINDO PHARMA 43/7.1.3/0494 AUROBINDO PHARMA 43/7.1.3/0495 AUROBINDO PHARMA 43/7.1.3/0496 AUROBINDO PHARMA 43/7.1.3/0497 AUROBINDO PHARMA 43/7.1.3/0498 AUROBINDO PHARMA NEXIAM 10 mg SACHETS NEVIVIR ATAZOR 100 ATAZOR 150 ATAZOR 200 MEDPLOZ 5 mg MEDPLOZ 10 mg AURO LOSARTAN TABLETS 25 mg AURO LOSARTAN TABLETS 50 mg AURO LOSARTAN TABLETS 100 mg RASOL 25 RASOL 50 RASOL 100 Each sachet ESOMEPRAZOLE 10,0 mg NEVIRAPINE 200,0 mg Each capsule ATAZANAVIR Each capsule ATAZANAVIR 1 Each capsule ATAZANAVIR 200,0 mg ZOLPIDEM TARTRATE 5,0 mg ZOLPIDEM TARTRATE 10,0 mg Notification of Feb11v1.doc Apr 2011 Page 7 of 8

8 43/20.2.8/0580 ARROW PHARMA 43/20.1.1/0647 JANSSEN PHARMACEUTICA (PTY) 43/18.8/0648 PHARMA DYNAMICS 43/20.1.6/0680 GLENMARK 43/30.1/0944 ROCHE PRODUCTS 43/30.1/0945 ROCHE PRODUCTS 43/30.1/0946 ROCHE PRODUCTS 44/20.2.8/0108 ADCOCK INGRAM LIMITED VIREF DORIBAX 500 mg RUBY SUPIROBAN ACTEMRA 80 ACTEMRA 200 ACTEMRA 400 PROPAN LAMIVUDINE AND ZIDOVUDINE 150/300 EFAVIRENZ 600,0 mg DORIPENEM MONOHYDRATE DORIPENEM 500,0 mg DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,03 mg Each 1,0 g ointment MUPIROCIN 2,0 mg Each 4,0 ml solution TOCILIZUMAB 80,0 mg Each 4,0 ml solution TOCILIZUMAB 200,0 mg Each 4,0 ml solution TOCILIZUMAB 400,0 mg LAMIVUDINE 1 ZIDOVUDINE 300,0 mg REGISTRAR OF MEDICINES MS MANDISA HELA Notification of Feb11v1.doc Apr 2011 Page 8 of 8

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 30/2.10/0392 TEVA TEVA BACLOFEN

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

EUROPEAN MEDICINES AGENCY DECISION. of 2 October 2009

EUROPEAN MEDICINES AGENCY DECISION. of 2 October 2009 European Medicines Agency Doc. Ref. EMEA/610520/2009 P/191/2009 EUROPEAN MEDICINES AGENCY DECISION of 2 October 2009 on the acceptance of a modification of an agreed Paediatric Investigation Plan for alanine,

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex peri Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully before you start using this medicine because it contains

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully. It provides a summary of information about your medicine.

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

Full Report (All Nutrients) 01174, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D

Full Report (All Nutrients) 01174, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D National base for Standard Reference Release 28 slightly revised May, 206 Full Report (All s) 074, Milk, reduced fat, fluid, 2% milkfat, without added vitamin A and vitamin D Report Date: February 23,

More information

Package leaflet: Information for the user. Nutriflex Omega plus Emulsion for infusion

Package leaflet: Information for the user. Nutriflex Omega plus Emulsion for infusion Package leaflet: Information for the user Nutriflex Omega plus Emulsion for infusion Read all of this leaflet carefully before you start using this medicine because it contains important information for

More information

STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS

STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS STANDARD 2.9.4 FORMULATED SUPPLEMENTARY SPORTS FOODS Purpose This Standard defines and regulates the composition and labelling of foods specially formulated to assist sports people in achieving specific

More information

Food for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria.

Food for special medical purposes. phenylketonuria (PKU) Important notice: Suitable only for individuals with proven phenylketonuria. PKU Nutri 1 Energy Food for special medical purposes. For the dietary management of proven phenylketonuria (PKU) in infants from birth to 12 months and as a supplementary feed up to 3 years. An amino acid

More information

MSUD HCU Tyrosinaemia MMA/PA IVA (for PKU cooler see pages 11-13)

MSUD HCU Tyrosinaemia MMA/PA IVA (for PKU cooler see pages 11-13) (for PKU see pages 11-13) + Description A food for special medical purposes. Cooler is a ready-to-drink protein substitute containing essential and non-essential amino acids (but excluding the offending

More information

Age-related reference ranges

Age-related reference ranges Authoriser: Peter Beresford Page 1 of 6 Age-related reference ranges Alkaline Phosphatase (ALP) IU/L Both less than 14 days 90 273 Both 14 days

More information

Product Information: Phenex -1

Product Information: Phenex -1 Product Information: Phenex -1 1 of 5 For nutrition support of infants and toddlers with phenylketonuria (PKU). Phenylalanine-free Use under medical supervision. Phenylalanine-free to allow greater intake

More information

Product Information: Propimex -1

Product Information: Propimex -1 Product Information: Propimex -1 1 of 5 Nutrition support of infants and toddlers with propionic or methylmalonic acidemia. Methionine- and valine-free; low in isoleucine and threonine. Use under medical

More information

Product Information: Tyrex -1

Product Information: Tyrex -1 Product Information: Tyrex -1 1 of 5 Nutrition support of infants and toddlers with tyrosinemia types I, II or III. Phenylalanine- and tyrosine-free. Use under medical supervision. Phenylalanine- and tyrosine-free

More information

Product Information: Ketonex -1

Product Information: Ketonex -1 Product Information: 1 of 5 Nutrition support of infants and toddlers with maple syrup urine disease (MSUD). Isoleucine-, leucine- and valine-free. Use under medical supervision. Branched-chain amino acid-free

More information

LAB#23: Biochemical Evidence of Evolution Name: Period Date :

LAB#23: Biochemical Evidence of Evolution Name: Period Date : LAB#23: Biochemical Evidence of Name: Period Date : Laboratory Experience #23 Bridge Worth 80 Lab Minutes If two organisms have similar portions of DNA (genes), these organisms will probably make similar

More information

Vamin 18 EF QUALITATIVE AND QUANTITATIVE COMPOSITION

Vamin 18 EF QUALITATIVE AND QUANTITATIVE COMPOSITION Title Page Information Dec. 2000 1 (7) Number Vamin 18 EF 121-01 1. NAME OF THE MEDICINAL PRODUCT Vamin 18 g N/l electrolyte-free infusion fluid, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1000

More information

ssniff Complete feeds for rabbits and guinea pigs *

ssniff Complete feeds for rabbits and guinea pigs * ssniff Complete feeds for rabbits and guinea pigs * Complete diets for all development and life stages Comparable to other animal species also for the breeding and rearing of guinea pigs and rabbits higher

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2001L0015 EN 11.04.2006 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COMMISSION DIRECTIVE 2001/15/EC of 15 February

More information

LIST OF FORMULATION PRODUCTS. Ferrocid Transule Capsule. Blended Pellets of Carbonyl Iron, Folic Acid & Zinc. Nature Biochem

LIST OF FORMULATION PRODUCTS. Ferrocid Transule Capsule. Blended Pellets of Carbonyl Iron, Folic Acid & Zinc. Nature Biochem LIST OF FORMULATION PRODUCTS Haematinics Ferrocid Transule Capsule Dried Ferrous Sulphate B.P. 1 Folic Acid B.P. 0.5 mg Eleron-F Dried Ferrous Sulphate I.P. 1 5 mg Cyanocobalamin I.P. 15 mcg Zinc Sulphate

More information

ssniff Complete feeds with low phytoestrogen content for rats and mice / nude rats and nude mice*

ssniff Complete feeds with low phytoestrogen content for rats and mice / nude rats and nude mice* ssniff Complete feeds with low phytoestrogen content for rats and mice / nude rats and nude mice* Complete diets for all development and life stages has producing various low-phytoestrogen diets (free

More information

Package leaflet: Information for the user. Kabiven Peripheral, emulsion for infusion

Package leaflet: Information for the user. Kabiven Peripheral, emulsion for infusion Package leaflet: Information for the user Kabiven Peripheral, emulsion for infusion Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

1. Describe the relationship of dietary protein and the health of major body systems.

1. Describe the relationship of dietary protein and the health of major body systems. Food Explorations Lab I: The Building Blocks STUDENT LAB INVESTIGATIONS Name: Lab Overview In this investigation, you will be constructing animal and plant proteins using beads to represent the amino acids.

More information

[NOTE The relative retention times for calcitonin salmon and calcitonin salmon related compound A Change to read:

[NOTE The relative retention times for calcitonin salmon and calcitonin salmon related compound A Change to read: . Mode: Revision Bulletin Official April 1, 2012 Calcitonin Salmon 1 LC Calcitonin Salmon Detector: UV 220 nm Column: 4.6-mm 25-cm; packing L1 Column temperature: 65 Flow rate: 1 ml/min Injection volume:

More information

Sesame seed powder * product is currently being developed. Chia powder * Product nr HP01 HP04 PU01 SS01 CH01 A01 FS01 FS02 P01 P02 R02

Sesame seed powder * product is currently being developed. Chia powder * Product nr HP01 HP04 PU01 SS01 CH01 A01 FS01 FS02 P01 P02 R02 Minerals and approved health claims 2 servings of 20 gr/day RDI (EU) mg/ day Source of 15% RDI (mg) Rich in 30% RDI (mg) - Belgian origin Pumpkin Sesame product is currently being developed Chia might

More information

Amino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3

Amino Acids. Amino Acids. Fundamentals. While their name implies that amino acids are compounds that contain an NH. 3 and CO NH 3 Fundamentals While their name implies that amino acids are compounds that contain an 2 group and a 2 group, these groups are actually present as 3 and 2 respectively. They are classified as α, β, γ, etc..

More information

T1-1 Table 1. Target compounds and individual food additives.

T1-1 Table 1. Target compounds and individual food additives. T1-1 Table 1. Target compounds and individual food additives. No. 1 Aspartame Sweetener Aspartame D 1 1 2 Xylitol Sweetener Xylitol D 2 2 3 Glycyrrhizine Sweetener Disodium glycyrrhizinate D 3 3 Licorice

More information

Soy Protein. Muscle health benefits: for Sports Nutrition Recovery and during aging. May 9, Mark Cope, PhD

Soy Protein. Muscle health benefits: for Sports Nutrition Recovery and during aging. May 9, Mark Cope, PhD Soy Protein Muscle health benefits: for Sports Nutrition Recovery and during aging May 9, 2017 Mark Cope, PhD Blending Proteins to Provide Better Muscle Health Importance of Muscle Health The Benefits

More information

Product Information: EleCare Jr

Product Information: EleCare Jr Product Information: EleCare Jr 1 of 5 A 30 Cal/fl oz, nutritionally complete amino acid-based medical food for children age 1 and older who cannot tolerate intact or hydrolyzed protein. EleCare Jr is

More information

Amino Acid Analyzer AAA400

Amino Acid Analyzer AAA400 Amino Acid Analyzer AAA400 Determination of amino acid of hydrolyzates (food and feed) Column: LG ANB OSTION 3.6x340 12μm Eluents: sodium-citrate buffers, 0.2 M NaOH Aspartic Acid, Threonine, Serine, Glutamic

More information

A COMPARISON OF WHEY PROTEIN CONCENTRATE AND SPRAY-DRIED ANIMAL PLASMA IN DIETS FOR WEANLING PIGS 1

A COMPARISON OF WHEY PROTEIN CONCENTRATE AND SPRAY-DRIED ANIMAL PLASMA IN DIETS FOR WEANLING PIGS 1 Swine Day 2004 A COMPARISON OF WHEY PROTEIN CONCENTRATE AND SPRAY-DRIED ANIMAL PLASMA IN DIETS FOR WEANLING PIGS 1 R. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, S. S. Dritz 2, J. L. Nelssen,

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DUPHALYTE Solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Composition per ml VITAMINS

More information

0010 Amino Acid Analysis - 40 Plasma

0010 Amino Acid Analysis - 40 Plasma 770.446.5483 770.441.2237 This report contains reference range adjustments from routine revalidation procedures. It also contains the following three upgrades: 1) The amino acids have been reorganized

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PRIMENE 10% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each litre of the infusion solution contains: L-Isoleucine L-Leucine L-Valine

More information

Proteins consist in whole or large part of amino acids. Simple proteins consist only of amino acids.

Proteins consist in whole or large part of amino acids. Simple proteins consist only of amino acids. Today we begin our discussion of the structure and properties of proteins. Proteins consist in whole or large part of amino acids. Simple proteins consist only of amino acids. Conjugated proteins contain

More information

Official Journal of the European Communities

Official Journal of the European Communities L 52/19 COMMISSION DIRECTIVE 2001/15/EC of 15 February 2001 on substances that may be added for specific nutritional purposes in foods for particular nutritional uses (Text with EEA relevance) THE COMMISSION

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% Amino Acid Intravenous Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Leucine Ph. Eur 0.620% w/v L-Isoleucine

More information

Lecture 3: 8/24. CHAPTER 3 Amino Acids

Lecture 3: 8/24. CHAPTER 3 Amino Acids Lecture 3: 8/24 CHAPTER 3 Amino Acids 1 Chapter 3 Outline 2 Amino Acid Are Biomolecules and their Atoms Can Be Visualized by Two Different Ways 1) Fischer projections: Two dimensional representation of

More information

R. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, J. L. Nelssen, S. S. Dritz 2, C. W. Hastad, K. R. Lawrence, and D. A.

R. O. Gottlob, J. M. DeRouchey, M. D. Tokach, R. D. Goodband, J. L. Nelssen, S. S. Dritz 2, C. W. Hastad, K. R. Lawrence, and D. A. Swine Day 2004 DETERMINATION OF THE APPARENT AND TRUE ILEAL AMINO ACID DIGESTIBILITY AND DIGESTIBLE AND METABOLIZABLE ENERGY OF SPECIALTY PROTEIN SOURCES INTENDED FOR NURSERY PIG DIETS 1 R. O. Gottlob,

More information

Product Information: EleCare (for Infants)

Product Information: EleCare (for Infants) 1 of 5 Product Information: 2 of 5 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who cannot tolerate intact or hydrolyzed protein. EleCare is indicated for the dietary management

More information

BODY CHEMISTRY TEST. Sample Report

BODY CHEMISTRY TEST. Sample Report BODY CHEMISTRY TEST * Sample Report Ver. 1.0, Date created: Nov 5, 2017 Disclaimer: VitaminLab is for informational purposes only. lease discuss your results or concerns with your health care professional

More information

0010 Amino Acids 40 Profile - Plasma

0010 Amino Acids 40 Profile - Plasma Accession #: Order #: G1234567 Date Collected: Date Received: 01/22/2013 Reference #: Patient: Date of Birth: 02/05/1962 Date of Report: Telephone: 7704464583 Ordering Physician: 1234 Main St. Anywhere,

More information

Product Category: EleCare

Product Category: EleCare EleCare Product Category: EleCare EleCare (for Infants) Updated 4/28/2016 Product Information: EleCare (for Infants) 1 of 4 A 20 Cal/fl oz, nutritionally complete amino acid-based formula for infants who

More information

Amino acids. (Foundation Block) Dr. Essa Sabi

Amino acids. (Foundation Block) Dr. Essa Sabi Amino acids (Foundation Block) Dr. Essa Sabi Learning outcomes What are the amino acids? General structure. Classification of amino acids. Optical properties. Amino acid configuration. Non-standard amino

More information

Public Assessment Report Scientific discussion. Numeta G16E and Numeta G19E

Public Assessment Report Scientific discussion. Numeta G16E and Numeta G19E Public Assessment Report Scientific discussion Numeta G16E and Numeta G19E Active substances: alanine, arginine, aspartic acid, cysteine, glucose, glutamic acid, glycine, histidine, isoleucine, leucine,

More information

PROTEIN. By: Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology UPM

PROTEIN. By: Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology UPM PROTEIN By: Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology UPM OBJECTIVES OF THE LECTURE By the end of this lecture, student can: Define

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761 GOVERNMENT GAZETTE OF THE REPUBLIC OF N$4.00 WINDHOEK - 26 July 2011 No. 4761 CONTENTS Page GOVERNMENT NOTICE No. 122 Registration of certain medicines: Medicines and Related Substances Control Act, 2003...

More information

CHAPTER FIVE: COMMERCIAL APPLICATIONS TABLE 12 COMMERCIAL AMINO ACIDS BY USE... 35

CHAPTER FIVE: COMMERCIAL APPLICATIONS TABLE 12 COMMERCIAL AMINO ACIDS BY USE... 35 CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS...

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003 GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$5.60 WINDHOEK - 31 July 2012 No. 5003 CONTENTS Page GOVERNMENT NOTICES No. 186 Cancellation of certain medicines: Medicines and Related Substances Control

More information

SUMMARY OF PRODUCT CHARACTERISTICS mg (6.85 mg)

SUMMARY OF PRODUCT CHARACTERISTICS mg (6.85 mg) SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aminoplasmal B. Braun 10% E Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The solution for infusion contains: per

More information

(a) (i) Describe how the production and action of interferon differs from the production and action of lysozyme. (3)

(a) (i) Describe how the production and action of interferon differs from the production and action of lysozyme. (3) 1 Histamine and the proteins interferon and lysozyme are involved in the non-specific responses to infection. (a) (i) escribe how the production and action of interferon differs from the production and

More information

What Are Proteins? Lecture 9: Proteins. Proteins: large complex molecules composed of amino acids. Nutrition 150 Shallin Busch, Ph.D.

What Are Proteins? Lecture 9: Proteins. Proteins: large complex molecules composed of amino acids. Nutrition 150 Shallin Busch, Ph.D. What Are Proteins? Lecture 9: Proteins Nutrition 150 Shallin Busch, Ph.D. Proteins: large complex molecules composed of amino acids. Contain carbon, hydrogen, oxygen, nitrogen Primary source of nitrogen

More information

Protein Folding LARP

Protein Folding LARP Protein Folding LARP Version: 1.0 Release: April 2018 Amplyus 2018 minipcr TM Protein Folding LARP (Live Action Role Play) Summary Materials In this activity, students will role play to make a folded protein

More information

DYMATIZE ELITE 100% WHEY The perfect anytime protein

DYMATIZE ELITE 100% WHEY The perfect anytime protein DYMATIZE ELITE 100% WHEY The perfect anytime protein Product description The perfect anytime protein! Are you looking for an anytime protein with great value? Whether you re supporting muscle growth after

More information

Package leaflet: Information for the user. Kabiven, emulsion for infusion

Package leaflet: Information for the user. Kabiven, emulsion for infusion Package leaflet: Information for the user, emulsion for infusion Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet.

More information

Visual evaluation of early (~ 4-cell) mammalian embryos. How well does it predict subsequent viability? Marie-Noël Bruné Rossel APPENDICES

Visual evaluation of early (~ 4-cell) mammalian embryos. How well does it predict subsequent viability? Marie-Noël Bruné Rossel APPENDICES Visual evaluation of early (~ 4-cell) mammalian embryos. How well does it predict subsequent viability? Marie-Noël Bruné Rossel APPENDICES 1) Glossary (alphabetical) (From the Aberdeen Fertility Centre

More information

Metabolism of Amino Acids in Aquatic Animals II

Metabolism of Amino Acids in Aquatic Animals II Mem. Fac. Fish., Kagoshima Univ. Vol. 26 pp. 45-48 (1977) Metabolism of Amino Acids in Aquatic Animals II The effect of an amino acid supplemented casein diet on the growth rate of carp Yoshito Tanaka,

More information

Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health

Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health Microbial Enhanced Fish Fertilizer Supplement with Vitamins and Nutrients for Plant Health INTRODUCTION: MicrobeBio Hydro Activator naturally occurring beneficial organisms, 100% organic proteins, and

More information

SGS Germany GmbH Rödingsmarkt 16 D Hamburg t f

SGS Germany GmbH Rödingsmarkt 16 D Hamburg t f SGS Germany GmbH Rödingsmarkt 16 20459 Hamburg Company Alfa Laval Copenhagen A/S Maskinvej 5 2860 SOEBORG DÄNEMARK Test Report 2589950 Order No. 3404715 Customer No. 10043639 Larissa Münzberg Phone +49

More information

EFFECT OF SOME AMINO ACIDS ON THE GROWTH AND L-GLUTAMIC ACID FERMENTATION BY AN AUXOTROPHIC MUTANT Micrococcus glutamicus AB 100.

EFFECT OF SOME AMINO ACIDS ON THE GROWTH AND L-GLUTAMIC ACID FERMENTATION BY AN AUXOTROPHIC MUTANT Micrococcus glutamicus AB 100. S. Ganguly et. al. / International Journal on Pharmaceutical and Biomedical Research (IJPBR) Vol. 2(1), 2011, 21-25 EFFECT OF SOME AMINO ACIDS ON THE GROWTH AND L-GLUTAMIC ACID FERMENTATION BY AN AUXOTROPHIC

More information

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726 GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.00 WINDHOEK - 3 June 2011 No. 4726 CONTENTS Page GOVERNMENT NOTICE No. 71 Medicines and Related Substances Control Act, 2003: Registration of certain medicines...

More information

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country

More information

Product Category: Amino Acid/Metabolics

Product Category: Amino Acid/Metabolics Amino Acid/Metabolics Product Category: Amino Acid/Metabolics Calcilo XD Cyclinex -1 Cyclinex -2 Glutarex -1 Glutarex -2 Hominex -1 Hominex -2 I-Valex -1 I-Valex -2 Ketonex -1 Ketonex -2 Phenex -1 Phenex

More information

So where were we? But what does the order mean? OK, so what's a protein? 4/1/11

So where were we? But what does the order mean? OK, so what's a protein? 4/1/11 So where were we? We know that DNA is responsible for heredity Chromosomes are long pieces of DNA DNA turned out to be the transforming principle We know that DNA is shaped like a long double helix, with

More information

COMPARISON OF INTERNATIONAL PROTEIN CORPORATION 740 FISH MEAL AND SPECIAL SELECT MENHADEN FISH MEAL IN NURSERY PIG DIETS

COMPARISON OF INTERNATIONAL PROTEIN CORPORATION 740 FISH MEAL AND SPECIAL SELECT MENHADEN FISH MEAL IN NURSERY PIG DIETS Swine Day 2001 Contents COMPARISON OF INTERNATIONAL PROTEIN CORPORATION 740 FISH MEAL AND SPECIAL SELECT MENHADEN FISH MEAL IN NURSERY PIG DIETS M. G. Young, M. D. Tokach, R. D. Goodband, J. L. Nelssen,

More information

Detox Suite. A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms.

Detox Suite. A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms. Detox Suite A collection of premium-quality professional formulas scientifically proven to support the body s natural detoxification mechanisms. Features/Use I 3 d Liver Rx Liver Balance DPO FUNCTIONAL

More information

AAFCO Proficiency Testing Program: 2016 Participation

AAFCO Proficiency Testing Program: 2016 Participation AAFCO Proficiency Testing Program: 206 Participation Lamb Feed, Medicated Swine Feed, Medicated 20632 2063 Poultry/Game Bird Feed Dairy Beef Feed Cattle Mineral Molasses Product, Dehydrated Cat Food, Dry

More information

Package leaflet: Information for the user. SmofKabiven emulsion for infusion

Package leaflet: Information for the user. SmofKabiven emulsion for infusion Package leaflet: Information for the user SmofKabiven emulsion for infusion Read all of this leaflet carefully before you start using this medicine because it contains important information for you. -

More information

MSUD HCU Tyrosinaemia MMA/PA GA gel (for PKU gel see pages 7-10)

MSUD HCU Tyrosinaemia MMA/PA GA gel (for PKU gel see pages 7-10) MSUD HCU Tyrosinaemia MMA/PA GA el (for PKU el see paes 7-10) Description A food for special medical purposes. Unflavoured powdered protein substitutes containin essential and non-essential amino acids

More information

M1 - Renal, Fall 2007

M1 - Renal, Fall 2007 University of Michigan Deep Blue deepblue.lib.umich.edu 2007-09 M1 - Renal, Fall 2007 Lyons, R.; Burney, R. Lyons, R., Burney, R. (2008, August 07). Renal. Retrieved from Open.Michigan - Educational Resources

More information

Amino acids-incorporated nanoflowers with an

Amino acids-incorporated nanoflowers with an Amino acids-incorporated nanoflowers with an intrinsic peroxidase-like activity Zhuo-Fu Wu 1,2,+, Zhi Wang 1,+, Ye Zhang 3, Ya-Li Ma 3, Cheng-Yan He 4, Heng Li 1, Lei Chen 1, Qi-Sheng Huo 3, Lei Wang 1,*

More information

Amino Acids and Sorbitol injection with/without Electrolytes NIRMIN *

Amino Acids and Sorbitol injection with/without Electrolytes NIRMIN * For the use of a registered medical practitioner or a Hospital or a Laboratory only Amino Acids and Sorbitol injection with/without Electrolytes NIRMIN * DESCRIPTION: NIRMIN * is a clear, colourless injection

More information

Kansas Agricultural Experiment Station Research Reports

Kansas Agricultural Experiment Station Research Reports Kansas Agricultural Experiment Station Research Reports Volume 0 Issue 10 Swine Day (1968-2014) Article 1092 2004 Determination of the apparent and true ileal amino acid digestibility and digestible and

More information

10 steps to buying the best protein

10 steps to buying the best protein 10 steps to buying the best protein 1. Ask yourself Do you exercise intensely or often? Then you may need more protein than the average person. Complementing your exercise regime and nutritious diet with

More information

Package leaflet: Information for the user. StructoKabiven emulsion for infusion

Package leaflet: Information for the user. StructoKabiven emulsion for infusion Package leaflet: Information for the user emulsion for infusion Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet.

More information

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product

More information

Objective: You will be able to explain how the subcomponents of

Objective: You will be able to explain how the subcomponents of Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:

More information

COMMISSION REGULATION (EC)

COMMISSION REGULATION (EC) 14.10.2009 Official Journal of the European Union L 269/9 COMMISSION REGULATION (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional in foods for particular nutritional

More information

ENDURANCE SPORTS NUTRITION

ENDURANCE SPORTS NUTRITION ENDURANCE SPORTS NUTRITION Complex carbohydrates with low glycemic index Simple carbohydrates with high glycemic index + complex carbs + proteins + electrolytes Simple carbs + complex carbs + proteins

More information

Thin-Layer Chromatography of Amino Acids HASPI Medical Biology Lab 15b Background Macromolecules

Thin-Layer Chromatography of Amino Acids HASPI Medical Biology Lab 15b Background Macromolecules Thin-Layer Chromatography of s HASPI Medical Biology Lab 15b Background Macromolecules Name: Period: Date: There are four major types of biological macromolecules that make up the human body: nucleic acids

More information

South Antarctic Krill (Euphausia superba, Dana)

South Antarctic Krill (Euphausia superba, Dana) Biological and Chemical Impact of Fishing Seasonality Impact in Krill Lipids (& Other Compounds) Period 80 s to 2000 s South Antarctic Krill (Euphausia superba, Dana) Summarized Tharos Information At-Sea

More information

CHAPTER FIVE: COMMERCIAL APPLICATIONS TABLE 12 COMMERCIAL AMINO ACIDS BY USE... 35

CHAPTER FIVE: COMMERCIAL APPLICATIONS TABLE 12 COMMERCIAL AMINO ACIDS BY USE... 35 CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 3 RELATED BCC REPORTS...

More information

SUPPLEMENTARY DATA Supplementary Figure 1. Body weight and fat mass of AdicerKO mice.

SUPPLEMENTARY DATA Supplementary Figure 1. Body weight and fat mass of AdicerKO mice. SUPPLEMENTARY DATA Supplementary Figure 1. Body weight and fat mass of AdicerKO mice. Twelve week old mice were subjected to ad libitum (AL) or dietary restriction (DR) regimens for three months. (A) Body

More information